GOLDMAN SACHS & CO. LLC - 24 Mar 2020 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Aug 2021, 18:41:31 UTC
Prior SEC filing
15 Jul 2021
Next SEC filing
06 Aug 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jamison Yardley, Attorney-in-fact

Key filing fact

GOLDMAN SACHS & CO. LLC filed Form 4 for T2 Biosystems, Inc. (TTOO) on 03 Aug 2021.

Key facts

  • This page summarizes GOLDMAN SACHS & CO. LLC's Form 4 filing for T2 Biosystems, Inc. (TTOO).
  • 30 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Aug 2021, 18:41.

Change

  • Previous filing in this sequence was filed on 15 Jul 2021.
  • Current net transaction value: +$4,116.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TTOO transaction

Common Stock

Purchase

Transaction value
$189
Shares
+500
Change %
+0.01%
Price
$0.3780
Shares after
4,196,956
Date
24 Mar 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$189
Shares
-500
Change %
-0.01%
Price
$0.3780
Shares after
4,196,456
Date
24 Mar 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Purchase

Transaction value
$557
Shares
+600
Change %
+0.01%
Price
$0.9279
Shares after
4,197,056
Date
25 Mar 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$557
Shares
-600
Change %
-0.01%
Price
$0.9279
Shares after
4,196,456
Date
25 Mar 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Purchase

Transaction value
$490
Shares
+1,000
Change %
+0.02%
Price
$0.4900
Shares after
4,197,456
Date
09 Apr 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$490
Shares
-1,000
Change %
-0.02%
Price
$0.4900
Shares after
4,196,456
Date
09 Apr 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$1,381
Shares
-2,655
Change %
-0.06%
Price
$0.5200
Shares after
4,193,801
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$521
Shares
-1,000
Change %
-0.02%
Price
$0.5210
Shares after
4,192,801
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$526
Shares
-1,000
Change %
-0.02%
Price
$0.5260
Shares after
4,191,801
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$264
Shares
-500
Change %
-0.01%
Price
$0.5280
Shares after
4,191,301
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$26.5
Shares
-50
Change %
-0%
Price
$0.5300
Shares after
4,191,251
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$266
Shares
-500
Change %
-0.01%
Price
$0.5318
Shares after
4,190,751
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$53.25
Shares
-100
Change %
-0%
Price
$0.5325
Shares after
4,190,651
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$3,378
Shares
-6,256
Change %
-0.15%
Price
$0.5400
Shares after
4,184,395
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$55
Shares
-100
Change %
-0%
Price
$0.5500
Shares after
4,184,295
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$517
Shares
-939
Change %
-0.02%
Price
$0.5503
Shares after
4,183,356
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Purchase

Transaction value
$14,455
Shares
+26,200
Change %
+0.63%
Price
$0.5517
Shares after
4,209,556
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$5,757
Shares
-10,100
Change %
-0.24%
Price
$0.5700
Shares after
4,199,456
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$1,140
Shares
-2,000
Change %
-0.05%
Price
$0.5701
Shares after
4,197,456
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$570
Shares
-1,000
Change %
-0.02%
Price
$0.5702
Shares after
4,196,456
Date
06 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Purchase

Transaction value
$1,365
Shares
+2,500
Change %
+0.06%
Price
$0.5460
Shares after
4,198,956
Date
12 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$1,365
Shares
-2,500
Change %
-0.06%
Price
$0.5460
Shares after
4,196,456
Date
12 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$166
Shares
-200
Change %
-0%
Price
$0.8314
Shares after
4,196,256
Date
19 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$2,691
Shares
-3,235
Change %
-0.08%
Price
$0.8318
Shares after
4,193,021
Date
19 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$1,691
Shares
-2,031
Change %
-0.05%
Price
$0.8325
Shares after
4,190,990
Date
19 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$1,691
Shares
-2,031
Change %
-0.05%
Price
$0.8326
Shares after
4,188,959
Date
19 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Purchase

Transaction value
$8,602
Shares
+10,328
Change %
+0.25%
Price
$0.8329
Shares after
4,199,287
Date
19 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$668
Shares
-800
Change %
-0.02%
Price
$0.8345
Shares after
4,198,487
Date
19 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Sale

Transaction value
$1,695
Shares
-2,031
Change %
-0.05%
Price
$0.8347
Shares after
4,196,456
Date
19 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
TTOO transaction

Common Stock

Purchase

Transaction value
$4,116
Shares
+5,126
Change %
+0.12%
Price
$0.8030
Shares after
4,201,582
Date
20 May 2020
Ownership
See Footnotes
Footnotes
F1, F2, F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These transactions in the common stock (the "Common Stock") of T2 Biosystems, Inc. (the "Issuer") have not previously been reported on Form 4 and were effected by Goldman Sachs & Co. LLC ("Goldman Sachs") acting as agent on behalf of certain international affiliates that had entered into riskless principal trades in connection with client trade facilitation in the ordinary course of their business.

Footnote F2

Without conceding riskless principal trades in connection with client trade facilitation in the ordinary course of business can result in liability under Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act"), the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that they were subject to Section 16(b) will be remitted to the Issuer.

Footnote F3

This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group") and Goldman Sachs (together, with GS Group, the "Reporting Persons"). Goldman Sachs is a subsidiary of GS Group.

Footnote F4

GS Group and Goldman Sachs may be deemed to beneficially own indirectly, in the aggregate, 4,157,240 shares of Common Stock of the Issuer by reason of the direct beneficial ownership of Common Stock by certain investment entities (the "GS Funds") because GS Group, or affiliates of GS Group and Goldman Sachs, are the general partner, managing general partner, managing partner, managing member or member of each of the GS Funds. Goldman Sachs beneficially owns directly and GS Group may be deemed to beneficially own indirectly 29,216 shares of common stock.

Footnote F5

Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.

SEC remarks

Balance of trades included in attached schedule. (See Exhibit 99.1)

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .